Early detection and favourable outcome of natalizumab-related progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis patients

Neurol Sci. 2015 Mar;36(3):489-91. doi: 10.1007/s10072-014-1918-y. Epub 2014 Aug 11.

Authors

Cinzia Cordioli¹, Nicola De Rossi, Sarah Rasia, Giovanni Lodoli, Ruggero Capra

Affiliation

¹ Regional Referring Center for Multiple Sclerosis, Spedali Civili of Brescia, Montichiari Hospital, Brescia, Italy, cinzia.cordioli@gmail.com.

PMID: 25109815
DOI: 10.1007/s10072-014-1918-y

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Brain / drug effects
Brain / pathology
Early Diagnosis
Female
Humans
Leukoencephalopathy, Progressive Multifocal / chemically induced*
Leukoencephalopathy, Progressive Multifocal / diagnosis*
Multiple Sclerosis, Relapsing-Remitting / complications*
Multiple Sclerosis, Relapsing-Remitting / drug therapy*
Natalizumab / adverse effects*
Natalizumab / therapeutic use

Substances

Natalizumab